SPS Webinar: Engineering Microscale Disease Models for Heart and Skeletal Muscle - June 11

SPS WEbinar.png

 

Dear Colleagues,


The Safety Pharmacology Society is pleased to invite you to a webinar presentation on Thursday, June 11, 2020 at 11:00 EDT/16:00 BST.

Title: Engineering Microscale Disease Models for Heart and Skeletal Muscle

Presenter: Megan L. McCain, PhD, University of Southern California

Description: 
The most common forms of heart disease are associated with pathological tissue remodeling secondary to an injury, such as a myocardial infarction. In contrast, most skeletal myopathies, such as amyotrophic lateral sclerosis, are caused by a genetic mutation that often has an impact on molecular, cellular, and tissue levels. Thus, regardless of their etiology, most diseases that afflict the heart and/or skeletal muscle involve several physical changes to the structure of the tissue that compound into electrophysiological and/or contractile deficits. However, existing model systems provide limited ability to both tune tissue microstructure and efficiently measure tissue function. In this talk, I will describe how we engineer tunable microscale models of healthy and diseased cardiac and skeletal muscle tissues and implement them to achieve new insights into heart and skeletal muscle physiology and pathophysiology.

Moderators:
Tessa de Korte, MSc, Ncardia and Khuram Chaudhary, PhD, Scientific Director, GlaxoSmithKline

 

Webinar Registration


This webinar is hosted by the SPS Academic Outreach Committee and is free to attend to all who are interested. We look forward to your participation.
  

Safety Pharmacology Society Headquarters

Recent Stories
Update on the 2020 DSP Certification Exam

Last Call! Safety Pharm Chats – Safety Pharmacology in 2030 (June 25)

2020 Distinguished Service Award Deferred